| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |